Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3801 - 3825 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Gangliosides LMSP0601DF08
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • KDN-GM1(d18:1/26:1(17Z))
44262603 1614.959663 C79H142N2O31
Gangliosides LMSP0601EB08
  • KDN-lactotetraosylceramide(d18:1/26:1(17Z))
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262763 1614.959663 C79H142N2O31
Gangliosides LMSP0601EC08
  • KDN(2-6)lactotetraosylceramide(d18:1/26:1(17Z))
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262771 1614.959663 C79H142N2O31
Gangliosides LMSP0601GE08
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263171 1614.959663 C79H142N2O31
Gangliosides LMSP0601GG08
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/26:1(17Z))
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263187 1614.959663 C79H142N2O31
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ03
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260294 1606.918193 C76H138N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260414 1606.918193 C76H138N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261630 1606.918193 C76H138N2O33
Diacylglycerophosphoinositolglycans LMGP15010200
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/14:0)
126457568 1606.774308 C70H127O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BH02
  • Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260429 1603.918527 C76H137N3O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AG02
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260533 1603.918527 C76H137N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AF02
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type I A antigen(d18:1/18:0)
44260653 1603.918527 C76H137N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AK02
  • Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260693 1603.918527 C76H137N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR02
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260749 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF02
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II A antigen(d18:1/18:0)
44261013 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG02
  • ClcNAc-Lex-5(d18:1/18:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261437 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CU02
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II A antigen(d18:1/18:0)
44261541 1603.918527 C76H137N3O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BI02
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261693 1603.918527 C76H137N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI04
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Leb(d18:1/22:0)
44260679 1602.959663 C78H142N2O31
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG04
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Ley-6(d18:1/22:0)
44261023 1602.959663 C78H142N2O31
Gangliosides LMSP0601AH04
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262023 1601.939262 C77H139N3O31
Gangliosides LMSP0601AP04
  • GM1(d18:1/22:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262087 1601.939262 C77H139N3O31
Gangliosides LMSP0601AY04
  • GM1b(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262159 1601.939262 C77H139N3O31
Gangliosides LMSP0601BM04
  • GM1alpha(d18:1/22:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262271 1601.939262 C77H139N3O31
Gangliosides LMSP0601DK04
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl-lactotetraosylceramide(d18:1/22:0)
44262631 1601.939262 C77H139N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024